Design, Recombinant Fusion Expression and Biological Evaluation of Vasoactive Intestinal Peptide Analogue as Novel Antimicrobial Agent

Design, Recombinant Fusion Expression and Biological Evaluation of Vasoactive Intestinal Peptide Analogue as Novel Antimicrobial Agent

Antimicrobial peptides represent an emerging category of therapeutic agents with remarkable structural and functional diversity. Modified vasoactive intestinal peptide (VIP) (VIP analogue 8 with amino acid sequence “FTANYTRLRRQLAVRRYLAAILGRR”) without haemolytic activity and cytotoxicity displayed e...

Full description

Bibliographic Details
Main Authors:	Chunlan Xu, Yu Guo, Xiangjin Qiao, Xiaoya Shang, Weining Niu, Mingliang Jin
Format:	Article
Language:	English
Published:	MDPI AG 2017-11-01
Series:	Molecules
Subjects:	vasoactive intestinal peptide analogue recombinant expression Escherichia coli antimicrobial activity
Online Access:	https://www.mdpi.com/1420-3049/22/11/1963

Similar Items

Chronic Diarrhea Caused by Vasoactive Intestinal Peptide-Secreting Tumor
by: Oana Belei, et al.
Published: (2023-09-01)

Vasoactive intestinal peptide in canine portosystemic shunt in the absence of portal hypertension
by: Mitsuhiro Isaka, et al.
Published: (2021-01-01)

Expression of motilin and vasoactive intestinal peptide in diverticular disease of the colon
by: Mikhail A. Osadchuk, et al.
Published: (2024-03-01)

Therapeutic effect of vasoactive intestinal peptide on form-deprived amblyopic kittens
by: Bo Li, et al.
Published: (2019-08-01)

Immunomodulatory role of vasoactive intestinal peptide and ghrelin in Oncorhynchus mykiss
by: Carolina Muñoz-Flores, et al.
Published: (2023-12-01)

Pressure-Dependent Elevation of Vasoactive Intestinal Peptide Level in Chicken Choroid
by: Evgeny Privalov, et al.
Published: (2023-03-01)

Vasoactive Intestinal Polypeptide Secreting MS Neuroblastoma
by: Josy Thomas, et al.
Published: (2024-11-01)

Effect of vasoactive intestinal peptide on the wound healing of alkali-burned corneas
by: Nese Tuncel, et al.
Published: (2016-02-01)

The role of vasoactive intestinal peptide (VIP) in atropine-related inhibition of the progression of myopia
by: Ying Wang, et al.
Published: (2024-01-01)

Non-specific activation of human eosinophil functional responses by vasoactive intestinal peptide
by: Amr El-Shazly, et al.
Published: (2000-01-01)

Induction of recombinant protein expression in Escherichia.coli using IPTG
by: Kok, Fook Seng, 1984-, author, et al.
Published: (2008)

Role of vasoactive intestinal peptide in Aspergillus fumigatus-infected cornea
by: Cui Li, et al.
Published: (2018-02-01)

Vasoactive intestinal peptide alleviates osteoarthritis effectively via inhibiting NF-κB signaling pathway
by: Yaozhong Liang, et al.
Published: (2018-03-01)

Role of tear vasoactive intestinal peptide on dry eyes after laser keratorefractive surgery
by: Yang Kang, et al.
Published: (2023-04-01)

Hydrogen and ethanol co-production by recombinant Escherichia coli SS1
by: Soo, Chiu Shyan
Published: (2016)

Periplasmic protein changes in response to over-expression of recombinant protein in escherichia coli
by: Heidary, Somayyeh
Published: (2013)

Attenuated serum vasoactive intestinal peptide concentrations are correlated with disease severity of non-traumatic osteonecrosis of femoral head
by: Ming Liu, et al.
Published: (2021-05-01)

Intracerebroventricular Infusion of Vasoactive Intestinal Peptide (VIP) Rescues the Luteinizing Hormone Surge in Middle-Aged Female Rats
by: Yan eSun, et al.
Published: (2012-02-01)

Vasoactive intestinal peptide degradation might influence Interleukin-17 expression in cardiac chagasic patients
by: Francielle Beltrão Pereira, et al.
Published: (2018-10-01)

Downstream processing of recombinant human insulin and its analogues production from E. coli inclusion bodies
by: Yin Yin Siew, et al.
Published: (2021-07-01)

Recombinant Production of Snakin-2 (an Antimicrobial Peptide from Tomato) in E. coli and Analysis of Its Bioactivity
by: Vera Herbel, et al.
Published: (2015-08-01)

Aviptadil- class effect of a synthetic vasoactive intestinal peptide as a treatment option in COVID-19 patients with severe respiratory failure
by: Dwaipayan Sarathi Chakraborty, et al.
Published: (2022-01-01)

Vasoactive intestinal peptide ameliorates renal injury in a pristane-induced lupus mouse model by modulating Th17/Treg balance
by: Dongdong Fu, et al.
Published: (2019-09-01)

Vasoactive intestinal peptide exerts therapeutic action by regulating PTEN in a model of Sjögren's disease
by: Yixi Li, et al.
Published: (2023-07-01)

Therapeutic potential of vasoactive intestinal peptide and its receptor VPAC2 in type 2 diabetes
by: Xintong Hou, et al.
Published: (2022-09-01)

OPTIMIZATION OF METHODS FOR PREPARATION OF RECOMBINANT TOBACCO ETCH VIRUS PROTEASE FROM <i>Escherichia coli </i>cells
by: A. V. Ryabchenko, et al.
Published: (2019-02-01)

VASOACTIVE DRUGS IN CRITICAL CARE
by: Dusper Silva, et al.
Published: (2014-07-01)

Vasoactive drugs in critical care
by: Dusper Silva, et al.
Published: (2014-07-01)

Vasoactive Intestinal Polypeptide Plays a Key Role in the Microbial-Neuroimmune Control of Intestinal MotilitySummary
by: Xiaopeng Bai, et al.
Published: (2024-01-01)

Isolation, Cloning and Expression of Recombinant Human Renin in Escherichia Coli System
by: Ng, Chyan Leong
Published: (2002)

Development of secretory expression system using synthetic signal peptides spA and spD for protein production in Escherichia coli.
by: Velaithan, Vithya
Published: (2011)

Effects of the Neuropeptides Pituitary Adenylate Cyclase Activating Polypeptide and Vasoactive Intestinal Peptide in Male Fertility
by: Roba Bdeir, et al.
Published: (2024-04-01)

Sudden hearing loss: Our experiences in treatment with vasoactive and corticosteroid therapy
by: Živić Ljubica, et al.
Published: (2012-01-01)

Increased Vasoactive Intestinal Peptide (VIP) in polycystic ovary syndrome patients undergoing IVF
by: Luana Sallicandro, et al.
Published: (2024-05-01)

CARDIOVASCULAR EFFECTS OF VASOACTIVE SUBSTANCES IN PROLONGED ANESTHESIA IN DOGS
by: Ljubica Spasojević Kosić, et al.
Published: (2012-08-01)

The Neural Signals of the Superior Ovarian Nerve Modulate in an Asymmetric Way the Ovarian Steroidogenic Response to the Vasoactive Intestinal Peptide
by: Gabriela Rosas, et al.
Published: (2018-08-01)

The effects of vasoactive intestinal peptide in the rat model of experimental autoimmune neuritis and the implications for treatment of acute inflammatory demyelinating polyradiculoneuropathy or Guillain–Barré syndrome
by: Jiao H, et al.
Published: (2018-11-01)

Endothelial vasoactive mediators in young patients with minor heart anomalies
by: A. V. Yagoda, et al.
Published: (2007-06-01)

Sudden hearing loss: Our experience in treatment with vasoactive therapy
by: Živić Ljubica, et al.
Published: (2008-01-01)

Prognostic evaluation of the norepinephrine equivalent score and the vasoactive-inotropic score in patients with sepsis and septic shock: a retrospective cohort study
by: Wenzhe Li, et al.
Published: (2024-08-01)